{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T04:24:34Z","timestamp":1650860674918},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,26]],"date-time":"2012-10-26T00:00:00Z","timestamp":1351209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s10157-012-0705-4","type":"journal-article","created":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T08:50:25Z","timestamp":1351155025000},"page":"294-303","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents"],"prefix":"10.1007","volume":"17","author":[{"given":"Terumasa","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Obi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Iio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenro","family":"Miyasato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Tsubakihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,26]]},"reference":[{"key":"705_CR1","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","volume":"355","author":"TB Drueke","year":"2006","unstructured":"Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355:2071\u201384.","journal-title":"N Engl J Med"},{"key":"705_CR2","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","volume":"355","author":"AK Singh","year":"2006","unstructured":"Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085\u201398.","journal-title":"N Engl J Med"},{"key":"705_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa0907845","volume":"361","author":"MA Pfeffer","year":"2009","unstructured":"Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Eng J Med. 2009;361:1\u201314.","journal-title":"N Eng J Med"},{"key":"705_CR4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","volume":"339","author":"A Besarab","year":"1998","unstructured":"Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al. The effect of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339:584\u201390.","journal-title":"N Engl J Med"},{"key":"705_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0306-4522(96)00306-5","volume":"76","author":"E Morishita","year":"1997","unstructured":"Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997;76:105\u201316.","journal-title":"Neuroscience"},{"key":"705_CR6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fj.03-1289fje","volume":"18","author":"GL Wright","year":"2004","unstructured":"Wright GL, Hanlon P, Amin K, Steenbergen C, Murphy E, Arcasoy MO. Erythropoietin receptor expression in adult rat cardiomyocytes in associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB J. 2004;18:1031\u20133.","journal-title":"FASEB J"},{"key":"705_CR7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1523-1755.1999.055003808.x","volume":"55","author":"C Westenfelder","year":"1999","unstructured":"Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int. 1999;55:808\u201320.","journal-title":"Kidney Int"},{"key":"705_CR8","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1182\/blood-2004-02-0744","volume":"104","author":"BB Beleslin-Cokic","year":"2004","unstructured":"Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood. 2004;104:2073\u201380.","journal-title":"Blood"},{"key":"705_CR9","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1073\/pnas.042693799","volume":"99","author":"M Celik","year":"2002","unstructured":"Celik M, G\u00f6kmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA. 2002;99:2258\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"705_CR10","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1073\/pnas.0630444100","volume":"100","author":"L Calvillo","year":"2003","unstructured":"Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA. 2003;100:4802\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"705_CR11","doi-asserted-by":"crossref","first-page":"H585","DOI":"10.1152\/ajpheart.00463.2008","volume":"296","author":"Y Naito","year":"2009","unstructured":"Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T. Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol. 2009;296:H585\u201393.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"705_CR12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.CIR.0000139335.04152.F3","volume":"24","author":"FH Bahlmann","year":"2004","unstructured":"Bahlmann FH, Song R, Boehm SM, Mengel M, von Wasielewski R, Lindschau C, et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation. 2004;24:1006\u201312.","journal-title":"Circulation"},{"key":"705_CR13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood-2003-04-1284","volume":"103","author":"FH Bahlmann","year":"2004","unstructured":"Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, Duckert T, et al. Erythropoietin regulates endothelial progenitor cells. Blood. 2004;103:921\u20136.","journal-title":"Blood"},{"key":"705_CR14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ki.1995.22","volume":"47","author":"RN Foley","year":"1995","unstructured":"Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186\u201392.","journal-title":"Kidney Int"},{"key":"705_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0272-6386(96)90357-1","volume":"27","author":"A Levin","year":"1996","unstructured":"Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27:347\u201354.","journal-title":"Am J Kidney Dis"},{"key":"705_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","volume":"34","author":"A Levin","year":"1999","unstructured":"Levin A, Thompson CR, Ethier J, Carlisle EJF, Tobe S, Mendelssohn D, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999;34:125\u201334.","journal-title":"Am J Kidney Dis"},{"key":"705_CR17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.ajkd.2005.04.031","volume":"46","author":"E Paoletti","year":"2005","unstructured":"Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis. 2005;46:320\u20137.","journal-title":"Am J Kidney Dis"},{"key":"705_CR18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.1992.390","volume":"42","author":"K Amann","year":"1992","unstructured":"Amann K, Wiest G, Zimmer G, Gretz N, Ritz E, Mall G. Reduced capillary density in the myocardium of uremic rats\u2014a stereological study. Kidney Int. 1992;42:1079\u201385.","journal-title":"Kidney Int"},{"key":"705_CR19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1681\/ASN.V75667","volume":"7","author":"J Torning","year":"1996","unstructured":"Torning J, Amann K, Ritz E, Nichols C, Zeier M, Mall G. Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol. 1996;7:667\u201375.","journal-title":"J Am Soc Nephrol"},{"key":"705_CR20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ki.1988.71","volume":"33","author":"G Mall","year":"1988","unstructured":"Mall G, Rambausek M, Neumeister A, Kollmar S, Vetterlein F, Ritz E. Myocardial interstitial fibrosis in experimental uremia: implications for cardiac compliance. Kidney Int. 1988;33:804\u201311.","journal-title":"Kidney Int"},{"key":"705_CR21","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1172\/JCI24682","volume":"115","author":"I Shiojima","year":"2005","unstructured":"Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. 2005;115:2108\u201318.","journal-title":"J Clin Invest"},{"key":"705_CR22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.HYP.0000215207.54689.31","volume":"47","author":"Y Izumiya","year":"2006","unstructured":"Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension. 2006;47:887\u201393.","journal-title":"Hypertension"},{"key":"705_CR23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05602","volume":"446","author":"M Sano","year":"2007","unstructured":"Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature. 2007;446:444\u20138.","journal-title":"Nature"},{"key":"705_CR24","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.106.659037","volume":"115","author":"Y Asaumi","year":"2007","unstructured":"Asaumi Y, Kagaya Y, Takeda M, Yamaguchi N, Tada H, Ito K, et al. Protective role of endogeneous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice. Circulation. 2007;115:2022\u201332.","journal-title":"Circulation"},{"key":"705_CR25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","volume":"36","author":"JS Silberberg","year":"1989","unstructured":"Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36:286\u201390.","journal-title":"Kidney Int"},{"key":"705_CR26","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1681\/ASN.V5122024","volume":"5","author":"RN Foley","year":"1995","unstructured":"Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol. 1995;5:2024\u201331.","journal-title":"J Am Soc Nephrol"},{"key":"705_CR27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/ndt\/11.7.1277","volume":"11","author":"PS Parfrey","year":"1996","unstructured":"Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996;11:1277\u201385.","journal-title":"Nephrol Dial Transplant"},{"key":"705_CR28","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1681\/ASN.2009060631","volume":"20","author":"KU Eckardt","year":"2009","unstructured":"Eckardt KU, Scherhag A, Macdougall IC, Tsakiris D, Clyne N, Locatelli F, et al. Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. J Am Soc Nephrol. 2009;20:2651\u201360.","journal-title":"J Am Soc Nephrol"},{"key":"705_CR29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80013-6","volume":"2","author":"NB Schiller","year":"1989","unstructured":"Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358\u201367.","journal-title":"J Am Soc Echocardiogr"},{"key":"705_CR30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","volume":"57","author":"RB Devereux","year":"1986","unstructured":"Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450\u20138.","journal-title":"Am J Cardiol"},{"key":"705_CR31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0002-9149(87)91133-7","volume":"59","author":"D Levy","year":"1987","unstructured":"Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castell WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham study. Am J Cardiol. 1987;59:956\u201360.","journal-title":"Am J Cardiol"},{"key":"705_CR32","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/01.CIR.43.4.480","volume":"43","author":"JF Pombo","year":"1971","unstructured":"Pombo JF, Troy BL, Russell RO Jr. Left ventricular volumes and ejection fractions by echocardiography. Circulation. 1971;43:480\u201390.","journal-title":"Circulation"},{"key":"705_CR33","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"705_CR34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/biomet\/69.1.239","volume":"69","author":"D Schoenfeld","year":"1982","unstructured":"Schoenfeld D. Partial residuals for the proportional hazards model. Biometrika. 1982;69:51\u20135.","journal-title":"Biometrika"},{"key":"705_CR35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1744-9987.2008.00634.x","volume":"12","author":"S Nakai","year":"2008","unstructured":"Nakai S, Masakane I, Akiba T, Shigematsu T, Yamagata K, Watanabe Y, et al. Overview of regular dialysis treatment in Japan as of 31 December 2006. Ther Apher Dial. 2008;12:428\u201356.","journal-title":"Ther Apher Dial"},{"key":"705_CR36","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/ndt\/gfp212","volume":"24","author":"AA Lopes","year":"2009","unstructured":"Lopes AA, Bragg-Gresham JL, Ramirez SP, Andreucci VE, Akiba T, Saito A, et al. Prescription of antihypertensive agents to haemodialysis patients: time trend and associations with patients\u2019 characteristics, country and survival in the DOPPS. Nephrol Dial Transplant. 2009;24:2809\u201316.","journal-title":"Nephrol Dial Transplant"},{"key":"705_CR37","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1093\/ndt\/gfm950","volume":"23","author":"M Chonchol","year":"2008","unstructured":"Chonchol M, Benderly M, Goldbourt U. Beta-blockers for coronary heart disease in chronic kidney disease. Nephrol Dial Transplant. 2008;23:2274\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"705_CR38","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","volume":"63","author":"K Kalantar-Zadeh","year":"2003","unstructured":"Kalantar-Zadeh K, Block G, Humphreys MH, Kopple J. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793\u2013808.","journal-title":"Kidney Int"},{"key":"705_CR39","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3324\/haematol.2010.025015","volume":"95","author":"L Lifshitz","year":"2010","unstructured":"Lifshitz L, Tabak G, Mittelman M, Gassmann M, Neumann D. Macrophages as novel targets for erythropoietin. Hematologica. 2010;95:1823\u201331.","journal-title":"Hematologica"},{"key":"705_CR40","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.transproceed.2008.03.033","volume":"40","author":"D Furlani","year":"2008","unstructured":"Furlani D, Klopsch C, Gabel R, Ugurlucan M, Pittermann E, Klee D, Wagner K, Li W, Wang W, Ong LL, Nizze H, Titze U, Lutzow K, Lendlein A, Steinhoff G, Ma N. Intracardiac erythropoietin injection reveals anti-inflammatory potential and improved cardiac functions detected by forced swim test. Transplant Proc. 2008;40:962\u20136.","journal-title":"Transplant Proc"},{"key":"705_CR41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2362.2009.02165.x","volume":"39","author":"N Shushakova","year":"2009","unstructured":"Shushakova N, Park JK, Menne J, Fliser D. Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyopathy in mouse. Eur J Clin Invest. 2009;39:755\u201360.","journal-title":"Eur J Clin Invest"},{"key":"705_CR42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0272-6386(00)70334-9","volume":"35","author":"T Hayashi","year":"2000","unstructured":"Hayashi T, Suzuki A, Shoji T, Togawa M, Okada N, Tsubakihara Y, et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis. 2000;35:250\u20136.","journal-title":"Am J Kidney Dis"},{"key":"705_CR43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1523-1755.2005.00458.x","volume":"68","author":"JC Ayus","year":"2005","unstructured":"Ayus JC, Go AS, Valderrabano F, Verde E, Garcia de Vinuesa S, Achinger SG, et al. Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10\u00a0g\/dl. Kidney Int. 2005;68:788\u201395.","journal-title":"Kidney Int"},{"key":"705_CR44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2215\/CJN.02730608","volume":"4","author":"PS Parfrey","year":"2009","unstructured":"Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P. Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: meta-analysis. Clin J Am Soc Nephrol. 2009;4:755\u201362.","journal-title":"Clin J Am Soc Nephrol"},{"key":"705_CR45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1681\/ASN.2009111127","volume":"21","author":"AK Singh","year":"2010","unstructured":"Singh AK. Dose TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol. 2010;21:2\u20136.","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-012-0705-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-012-0705-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-012-0705-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T14:27:38Z","timestamp":1643552858000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-012-0705-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,26]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["705"],"URL":"https:\/\/doi.org\/10.1007\/s10157-012-0705-4","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,26]]}}}